University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis : A pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales

Simple item page
dc.contributor.authorKerr, Steven
dc.contributor.authorJoy, Mark
dc.contributor.authorTorabi, Fatemeh
dc.contributor.authorBedston, Stuart
dc.contributor.authorAkbari, Ashley
dc.contributor.authorAgrawal, Utkarsh
dc.contributor.authorBeggs, Jillian
dc.contributor.authorBradley, Declan
dc.contributor.authorChuter, Antony
dc.contributor.authorDocherty, Annemarie B.
dc.contributor.authorFord, David
dc.contributor.authorHobbs, Richard
dc.contributor.authorKatikireddi, Srinivasa Vittal
dc.contributor.authorLowthian, Emily
dc.contributor.authorde Lusignan, Simon
dc.contributor.authorLyons, Ronan
dc.contributor.authorMarple, James
dc.contributor.authorMcCowan, Colin
dc.contributor.authorMcGagh, Dylan
dc.contributor.authorMcMenamin, Jim
dc.contributor.authorMoore, Emily
dc.contributor.authorMurray, Josephine L.K.
dc.contributor.authorOwen, Rhiannon K.
dc.contributor.authorPan, Jiafeng
dc.contributor.authorRitchie, Lewis
dc.contributor.authorShah, Syed Ahmar
dc.contributor.authorShi, Ting
dc.contributor.authorStock, Sarah
dc.contributor.authorTsang, Ruby S.M.
dc.contributor.authorVasileiou, Eleftheria
dc.contributor.authorWoolhouse, Mark
dc.contributor.authorSimpson, Colin R.
dc.contributor.authorRobertson, Chris
dc.contributor.authorSheikh, Aziz
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.date.accessioned2022-04-07T08:56:01Z
dc.date.available2022-04-07T08:56:01Z
dc.date.issued2022-02-28
dc.descriptionThis research is part of the Data and Connectivity National Core Study, led by Health Data Research UK in partnership with the Office for National Statistics and funded by UK Research and Innovation (grant ref MC_PC_20029, AS). EAVE II is funded by the Medical Research Council (https://mrc.ukri.org/) (UKRI MC_PC 19075, AS) with the support of BREATHE, The Health Data Research Hub for Respiratory Health (MC_PC_19004, AS), which is funded through the UK Research and Innovation Industrial Strategy Challenge Fund and delivered through Health Data Research UK. This work was supported by the Con-COV team funded by the Medical Research Council (grant number: MR/V028367/1, RL). This work was supported by Health Data Research UK, which receives its funding from HDR UK Ltd (HDR-9006, RL) funded by the UK Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Department of Health and Social Care (England), Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government), Public Health Agency (Northern Ireland), British Heart Foundation (BHF) and the Wellcome Trust. This work was supported by the ADR Wales programme of work (https://www.adruk.org/). The ADR Wales programme of work is aligned to the priority themes as identified in the Welsh Government’s national strategy: Prosperity for All. ADR Wales brings together data science experts at Swansea University Medical School, staff from the Wales Institute of Social and Economic Research, Data and Methods (WISERD) at Cardiff University and specialist teams within the Welsh Government to develop new evidence which supports Prosperity for All by using the SAIL Databank at Swansea University, to link and analyse anonymised data. ADR Wales is part of the Economic and Social Research Council (part of UK Research and Innovation) funded ADR UK (grant ES/S007393/1, RL). SVK acknowledges funding from NHS Research Scotland Senior Clinical Fellowship (SCAF/15/02, SVK), the MRC (MC_UU_00022/2, SVK), and the Scottish Government Chief Scientist Office (SPHSU17, SVK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.en
dc.description.statusPeer revieweden
dc.format.extent17
dc.format.extent1039438
dc.identifier215113348
dc.identifieraec80277-7504-4888-988f-4b45b5f52514
dc.identifier85125154473
dc.identifier35192598
dc.identifier.citationKerr, S, Joy, M, Torabi, F, Bedston, S, Akbari, A, Agrawal, U, Beggs, J, Bradley, D, Chuter, A, Docherty, A B, Ford, D, Hobbs, R, Katikireddi, S V, Lowthian, E, de Lusignan, S, Lyons, R, Marple, J, McCowan, C, McGagh, D, McMenamin, J, Moore, E, Murray, J L K, Owen, R K, Pan, J, Ritchie, L, Shah, S A, Shi, T, Stock, S, Tsang, R S M, Vasileiou, E, Woolhouse, M, Simpson, C R, Robertson, C & Sheikh, A 2022, 'First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis : A pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales', PLoS Medicine, vol. 19, no. 2, e1003927. https://doi.org/10.1371/journal.pmed.1003927en
dc.identifier.doi10.1371/journal.pmed.1003927
dc.identifier.iss2en
dc.identifier.issn1549-1277
dc.identifier.urihttps://hdl.handle.net/2164/18362
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85125154473&partnerID=8YFLogxKen
dc.identifier.vol19en
dc.language.isoeng
dc.relation.ispartofPLoS Medicineen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectR Medicineen
dc.subjectGeneral Medicineen
dc.subjectMedical Research Council (MRC)en
dc.subjectMR/V028367/1en
dc.subjectEconomic and Social Research Council (ESRC)en
dc.subjectES/S007393/1en
dc.subjectSupplementary Dataen
dc.subject.lccRen
dc.titleFirst dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis : A pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Walesen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Kerr_etal_pmed_First_Dose_VOR.pdf
Size:
1015.08 KB
Format:
Adobe Portable Document Format
Download

Collections

All research